Publications by authors named "Elodie Valade"

Claim this Profile
E
Erdafitinib's effect on serum phosphate justifies its pharmacodynamically guided dosing in patients with cancer.
Anne-Gaëlle Dosne, Elodie Valade, Kim Stuyckens, Peter De Porre, Anjali Avadhani

CPT Pharmacometrics Syst Pharmacol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposure-response analyses of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma.
Anne-Gaëlle Dosne, Elodie Valade, Nele Goeyvaerts, Peter De Porre, Anjali Avadhani

Cancer Chemother Pharmacol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population Pharmacokinetics of Total and Free Erdafitinib in Adult Healthy Volunteers and Cancer Patients: Analysis of Phase 1 and Phase 2 Studies.
Anne-Gaelle Dosne, Elodie Valade, Kim Stuyckens, Lilian Y Li, Daniele Ouellet

J Clin Pharmacol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of the effect of erdafitinib on cardiac safety: analysis of ECGs and exposure-QTc in patients with advanced or refractory solid tumors.
Elodie Valade, Anne-Gaëlle Dosne, Hong Xie, Robert Kleiman, Lilian Y Li

Cancer Chemother Pharmacol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterizing the Pharmacokinetic Interaction Between Simeprevir and Odalasvir in Healthy Volunteers Using a Population Modeling Approach.
Elodie Valade, Belén Valenzuela, Thomas N Kakuda, Christopher Westland, Matthew W McClure

AAPS J· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population Pharmacokinetics of AL-335 and Its Two Main Metabolites (ALS-022399, ALS-022227) in Monotherapy and in Combination with Odalasvir and/or Simeprevir.
Elodie Valade, Thomas N Kakuda, Matthew W McClure, Christopher Westland, Belén Valenzuela

AAPS J· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Physiologically-Based Pharmacokinetic Model to Predict Human Fetal Exposure for a Drug Metabolized by Several CYP450 Pathways.
Maïlys De Sousa Mendes, Gabrielle Lui, Yi Zheng, Claire Pressiat, Deborah Hirt, Elodie Valade

Clin Pharmacokinet· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population Pharmacokinetic Modeling of Tenofovir in the Genital Tract of Male HIV-Infected Patients.
Elodie Valade, Naïm Bouazza, Gabrielle Lui, Silvia M Illamola, Sihem Benaboud

Antimicrob Agents Chemother· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of human fetal pharmacokinetics using ex vivo human placenta perfusion studies and physiologically based models.
Maïlys De Sousa Mendes, Deborah Hirt, Cécile Vinot, Elodie Valade, Gabrielle Lui

Br J Clin Pharmacol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physiologically-based pharmacokinetic modeling of renally excreted antiretroviral drugs in pregnant women.
Maïlys De Sousa Mendes, Deborah Hirt, Saik Urien, Elodie Valade, Naïm Bouazza

Br J Clin Pharmacol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emtricitabine seminal plasma and blood plasma population pharmacokinetics in HIV-infected men in the EVARIST ANRS-EP 49 study.
Elodie Valade, Jean-Marc Tréluyer, Silvia M Illamola, Naïm Bouazza, Frantz Foissac

Antimicrob Agents Chemother· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population approach to analyze the pharmacokinetics of free and total lopinavir in HIV-infected pregnant women and consequences for dose adjustment.
Floris Fauchet, Jean-Marc Treluyer, Silvia M Illamola, Claire Pressiat, Gabrielle Lui, Elodie Valade

Antimicrob Agents Chemother· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of drug clearance in children.
Frantz Foissac, Naïm Bouazza, Elodie Valade, Mailys De Sousa Mendes, Floris Fauchet

J Clin Pharmacol· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modified renal function in pregnancy: impact on emtricitabine pharmacokinetics.
Elodie Valade, Jean-Marc Tréluyer, François Dabis, Elise Arrivé, Emmanuelle Pannier

Br J Clin Pharmacol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maternal and fetal zidovudine pharmacokinetics during pregnancy and labour: too high dose infused at labour?
Floris Fauchet, Jean-Marc Treluyer, Elodie Valade, Sihem Benaboud, Emmanuelle Pannier

Br J Clin Pharmacol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of emtricitabine in HIV-1-infected adult patients.
Elodie Valade, Jean-Marc Tréluyer, Naïm Bouazza, Jade Ghosn, Frantz Foissac

Antimicrob Agents Chemother· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of abacavir in pregnant women.
Floris Fauchet, Jean-Marc Treluyer, Laure-Helene Préta, Elodie Valade, Emmanuelle Pannier

Antimicrob Agents Chemother· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis